Related Experiment Video
Updated: Jul 13, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphoma
Jonathan Tward1, Martha Glenn, Michael Pulsipher
1Huntsman Cancer Hospital, University of Utah, UT 84112-5560, USA. Jonathan.Tward@hci.utah.edu
Abstract:
Most Non-Hodgkin's Lymphoma patients will survive their diagnosis. High dose chemotherapy and autologous stem cell transplantation, and radiation therapy have all been implicated as risk factors to secondary cancer development. Herein, we will review the molecular biology, examine the epidemiologic findings, discuss the impact of both chemotherapy and radiotherapy, and focus on the special populations of pediatrics and high dose chemotherapy and autologous stem cell transplantation with regard to secondary cancer development.
Related Concept Videos
Cancer Prevention
Some...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Cancers Originate from Somatic Mutations in a Single Cell
The Intrinsic Apoptotic Pathway
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
